FWCGX | GDGSX | FWCGX / GDGSX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 16 years | - |
Gain YTD | 4.361 | 2.482 | 176% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 5000 | 5% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 128B | 56M | 228,571% |
Annual Yield % from dividends | 1.94 | 0.75 | 257% |
Returns for 1 year | 7.40 | 13.32 | 56% |
Returns for 3 years | 19.98 | 32.00 | 62% |
Returns for 5 years | N/A | 62.95 | - |
Returns for 10 years | N/A | 112.87 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GIRNX | 28.53 | -0.09 | -0.31% |
Goldman Sachs International Eq ESG Inv | |||
MCEMX | 13.45 | -0.08 | -0.59% |
Martin Currie Emerging Markets IS | |||
OIEFX | 24.42 | -0.29 | -1.17% |
JPMorgan Equity Income R2 | |||
AHSAX | 19.71 | -0.31 | -1.55% |
Alger Health Sciences A | |||
RSECX | 16.29 | -0.33 | -1.99% |
Russell Inv US Strategic Equity C |